APG Asset Management US’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $267K | Hold |
2,087
| – | – | ﹤0.01% | 183 |
|
|
2025
Q1 | $223K | Hold |
2,087
| – | – | ﹤0.01% | 198 |
|
|
2024
Q4 | $285K | Sell |
2,087
-224
| -10% | -$30.6K | ﹤0.01% | 194 |
|
|
2024
Q3 | $264K | Sell |
2,311
-25,642
| -92% | -$2.93M | ﹤0.01% | 153 |
|
|
2024
Q2 | $3.92M | Buy |
27,953
+721
| +3% | +$101K | 0.02% | 154 |
|
|
2024
Q1 | $3.85M | Buy |
27,232
+8,698
| +47% | +$1.23M | 0.02% | 159 |
|
|
2023
Q4 | $2.44M | Buy |
+18,534
| New | +$2.44M | 0.02% | 169 |
|